Résultats de la recherche - 116 results
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
lower response to the vaccine such as anti- CD19, anti- CD20 or anti- CD38 therapies, low (naive) CD4 T-cell counts, genetic or therapeutic Bruton tyrosine kinase deficiency, treatment with ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
both before and after vaccination and was not majorly affected by different anti-cancer treatments. CONCLUSION: We propose a blood-based signature of cytokines and growth factors that can be employed in ...
Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol
any individual-level data, will be performed with the objective to reveal patients’ baseline characteristics, biomarkers, determinants of COVID-19 prognosis, safety and effectiveness of treatments, and ...
Movements of free-range pigs in rural communities in Zambia: an explorative study towards future ring interventions for the control of Taenia solium
urgently needed to control the disease. Geographically targeted interventions, i.e. screening or treatment of taeniosis among people living near infected pigs (defined as ring screening and ring treatment ...
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.
Treatment Outcome Vaccine Efficacy Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Manuscript versions: DOI: ...
Estimating the direct Disability-Adjusted Life Years associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
contributed to 98.5% of the DALY s. Of total symptomatic cases, 6.5% required hospitalisation and of those hospitalised 10.8% required intensive care unit treatment. COVID-19 was likely to be the second highest ...
Healthcare-associated infections and antimicrobial use in Belgian nursing homes: results of three point prevalence surveys between 2010 and 2016
treatment of an infection: 66.4% in HALT-1, 60.9% in HALT-2 and 64.1% in HALT-3. Uroprophylaxis accounted for 28.7%, 35.6% and 28.4% of all prescriptions, respectively. Conclusions None withstanding the ...
Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol.
effectiveness of treatments, and potential strategies against COVID-19, as well as epidemiological patterns. These analyses will complement evidence from efficacy/safety clinical trials, where vulnerable, more ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
patients are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). However, the safety and efficacy of COVID-19 vaccination in cancer patients undergoing treatment remain unclear. ...
Infective endocarditis caused by on a prosthetic pulmonary valve with false positive serology for- The first described case.
(TOF). The patient underwent valve replacement surgery and active antibiotic treatment against Gram-negative cocci (Piperacillin Tazobactam then Ceftriaxone) for a total duration of 42 days with ...